retatrutide phase 2 trial type 2 diabetes weight loss 2024 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Retatrutide—A Game Changer in Obesity

Endocrinologia, Diabetes y Nutricion, 64 (5), 278280

Injectable Semaglutide and Levothyroxine While the formal pharmacokinetic study examined oral semaglutide specifically, injectable semaglutide (Ozempic, Wegovy) and tirzepatide also slow gastric emptying

Injectables can over-plump or distort facial contours if not done carefully, and surgical options are invasive and irreversible

The progression is straightforward: semaglutide targets one receptor pathway and achieves approximately 1517% weight reduction in trials

Over the counter antihistamines like diphenhydramine (Benadryl) or cetirizine (Zyrtec) can reduce itching and minor allergic type reactions at injection sites

Wegovy (semaglutide injection) Product Monograph